SBL-JP-0004: A promising dual inhibitor of JAK2 and PI3KCD against gastric cancer

The results highlight SBL-JP-0004 as a promising dual inhibitor targeting JAK2 and PI3KCD kinases for treating GC and warrant further preclinical and clinical investigations to validate its utility in clinical settings.

Authors

Hassan M. Otifi (ORCID: https://orcid.org/0000-0002-1735-6041)

Institutions

King Khalid University (SA)

Publication Details

Journal: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Published: 2024-12-13
DOI: https://doi.org/10.32604/or.2024.055677
Citations: 2
Primary Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.88

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

SBL-JP-0004: A promising dual inhibitor of JAK2 and PI3KCD against gastric cancer

Hassan M. Otifi

Dec 13, 2024

2 citations

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Myeloproliferative Neoplasms: Diagnosis and Treatment

0.88

article

SBL-JP-0004: A promising dual inhibitor of JAK2 and PI3KCD against gastric cancer

Hassan M. Otifi

December 13, 2024article en

2 citations

Abstract

Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsVol. 33(1)

King Khalid University (SA)

Good health and well-being

Openalex Percentile: Top 22%

Myeloproliferative Neoplasms: Diagnosis and Treatment

0.88

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SBL-JP-0004: A promising dual inhibitor of JAK2 and PI3KCD against gastric cancer — Hassan M. Otifi · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) | TGRS Research Map | TGRS